An expanded plectin IHC analysis by Bausch et al. revealed that esophageal, stomach, and lung cancers also show high differential expression compared to non-malignant tissue, suggesting that plectin could serve as a biomarker in other cancers [32]. The gene discussed is PLEC; the disease is cancer.